Raku Co., Ltd Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
November 11, 2021
Share
Raku Co., Ltd reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was TWD 124.92 million compared to TWD 130.22 million a year ago. Revenue was TWD 124.92 million compared to TWD 130.22 million a year ago. Net loss was TWD 19.58 million compared to TWD 22.13 million a year ago. Basic loss per share from continuing operations was TWD 0.54 compared to TWD 0.91 a year ago.
For the nine months, sales was TWD 332.71 million compared to TWD 418.01 million a year ago. Revenue was TWD 332.71 million compared to TWD 418.01 million a year ago. Net loss was TWD 58.51 million compared to TWD 1.15 million a year ago. Basic loss per share from continuing operations was TWD 1.85 compared to TWD 0.05 a year ago.
Raku Co Ltd, formerly Kino Biotech Co., Ltd., is a Singapore-based company. The Company is an integrated bio-nutraceutical and cosmeceutical company. The Company is focused on product conceptualization, development, commercialization, brand marketing, sale and distribution of healthcare and beauty products. The Company provides healthcare and beauty products and services through brands, including Kinohimitsu, Activa and Xpertise. It has over two logistic and distribution centers in Malaysia and China. The Company provides products to China, Singapore, Malaysia, Vietnam, Thailand and Indonesia.
RAKU CO., LTD 
